Literature DB >> 2412930

Liver adenomatosis. An entity distinct from liver adenoma?

J F Flejou, J Barge, Y Menu, C Degott, H Bismuth, F Potet, J P Benhamou.   

Abstract

From 1979 to 1984, we followed the cases of 3 men (aged 13, 31, and 75 yr) and 2 women (aged 38 and 45 yr who had never used oral contraceptives) suffering from liver adenomatosis, an uncommon lesion consisting of numerous benign adenomas in an otherwise normal hepatic parenchyma. During the same period, we observed 20 cases of liver adenoma (one tumor in 18 patients and two tumors in 2 patients). From these cases and the review of previously reported cases of liver adenomatosis and series of liver adenoma, the following distinctive characteristics of these two benign conditions of the liver can be outlined: liver adenomatosis affects men and women, whereas liver adenoma predominantly affects women; liver adenomatosis is unrelated, whereas liver adenoma is closely related, to oral contraceptive use; increases in serum alkaline phosphatase and gamma-glutamyl transpeptidase are common in liver adenomatosis, but are uncommon in liver adenoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412930

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  54 in total

Review 1.  The changing face of hepatic resection.

Authors:  S Iwatsuki; D G Sheahan; T E Starzl
Journal:  Curr Probl Surg       Date:  1989-05       Impact factor: 1.909

Review 2.  Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature.

Authors:  L Chiche; T Dao; E Salamé; M P Galais; N Bouvard; G Schmutz; P Rousselot; P Bioulac-Sage; P Ségol; M Gignoux
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 3.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

4.  Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization.

Authors:  Sawako Kobayashi; Hiroki Sakaguchi; Masaki Takatsuka; Takehisa Suekane; Shuji Iwai; Hiroyasu Morikawa; Masaru Enomoto; Akihiro Tamori; Norifumi Kawada
Journal:  Hepatol Int       Date:  2009-03-05       Impact factor: 6.047

5.  Nodular regenerative hyperplasia of the liver: coral atoll-like lesions on ultrasound are characteristic in predisposed patients.

Authors:  E Caturelli; G Ghittoni; T V Ranalli; V V Gomes
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

6.  Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation.

Authors:  N Shao; A Pandey; M A Ghasabeh; P Khoshpouri; P Pandey; F N Varzaneh; M Zarghampour; D Fouladi; T M Pawlik; R A Anders; I R Kamel
Journal:  Clin Radiol       Date:  2018-07-18       Impact factor: 2.350

7.  Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Satoshi Sekiguchi; Kazuyuki Ishida; Takehiko Igarashi; Yuta Wakui; Takao Iwasaki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  Hepatocellular adenoma: what is new in 2008.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Christophe Laurent; Jessica Zucman-Rossi; Charles Balabaud
Journal:  Hepatol Int       Date:  2008-05-01       Impact factor: 6.047

9.  Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.

Authors:  Emmanuelle Jeannot; Lucille Mellottee; Paulette Bioulac-Sage; Charles Balabaud; Jean-Yves Scoazec; Jeanne Tran Van Nhieu; Yannick Bacq; Sophie Michalak; David Buob; Pierre Laurent-Puig; Ivan Rusyn; Jessica Zucman-Rossi
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.